Eiko Lifesciences has informed that the meeting of the Board of Directors of the Company is scheduled on 21/10/2022, to consider and approve unaudited financial results of the Company for the quarter and half year ended September 30, 2022.
The above information is a part of company’s filings submitted to BSE.